Equitable Trust CO Edwards Lifesciences Corp Transaction History

Equitable Trust CO

$1.47 Billion
Q3 2024

A detailed history of Equitable Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Equitable Trust CO holds 65,888 shares of EW stock, worth $4.71 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

65,888

Previous 13,734 379.74%

Holding current value

$4.71 Million

Previous $1.27 Million 242.82%

% of portfolio

0.3%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$59.7 - $93.78 $3.11 Million - $4.89 Million	52,154 Added 379.74%	65,888 $4.35 Million
Q2 2024 Aug 01, 2024	BUY	$84.3 - $94.31 $178,294 - $199,465	2,115 Added 18.2%	13,734 $1.27 Million
Q1 2024 Apr 25, 2024	BUY	$72.54 - $95.56 $69,783 - $91,928	962 Added 9.03%	11,619 $1.11 Million
Q4 2023 Jan 25, 2024	BUY	$61.71 - $77.76 $316,510 - $398,831	5,129 Added 92.78%	10,657 $812,000
Q3 2023 Nov 07, 2023	BUY	$69.28 - $93.38 $36,094 - $48,650	521 Added 10.41%	5,528 $382,000
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $16,037 - $18,583	197 Added 4.1%	5,007 $472,000
Q4 2022 Feb 21, 2023	BUY	$68.3 - $87.44 $89,336 - $114,371	1,308 Added 37.35%	4,810 $358,000
Q2 2022 Jul 15, 2022	BUY	$86.5 - $128.27 $17,473 - $25,910	202 Added 6.12%	3,502 $333,000
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $351,021 - $431,244	3,300 New	3,300 $428,000
Q3 2021 Oct 26, 2021	SELL	$102.91 - $122.75 $546,760 - $652,170	-5,313 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$83.84 - $104.76 $409,390 - $511,543	-4,883 Reduced 47.89%	5,313 $550,000
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $29,607 - $37,677	413 Added 4.22%	10,196 $930,000
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $24,591 - $32,003	-366 Reduced 3.61%	9,783 $781,000
Q2 2020 Aug 18, 2020	BUY	$57.54 - $76.95 $351,454 - $470,010	6,108 Added 151.15%	10,149 $702,000
Q1 2020 May 21, 2020	BUY	$52.41 - $81.0 $147,848 - $228,501	2,821 Added 231.23%	4,041 $762,000
Q2 2019 Aug 16, 2019	SELL	$55.74 - $64.41 $3,957 - $4,573	-71 Reduced 5.5%	1,220 $225,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $61,825 - $82,688	1,291 New	1,291 $247,000
Q4 2018 Feb 22, 2019	SELL	$46.41 - $56.94 $56,620 - $69,466	-1,220 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$45.7 - $58.03 $55,754 - $70,796	1,220 New	1,220 $212,000

Others Institutions Holding EW

# of Institutions

1,349

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Edwards Lifesciences Corp Transaction History